Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C-RAD B | CRADB | Apr 30, 2024 | 39.45 | +2.47 |
Cadeler | CADLRO | Apr 30, 2024 | 53.20 | +2.31 |
CAG Group | CAG | Apr 30, 2024 | 107.50 | +0.47 |
Calliditas Therapeutics | CALTX | Apr 30, 2024 | 110.00 | +2.90 |
Camurus | CAMX | Apr 30, 2024 | 498.20 | +0.36 |
Candles Scandinavia | CANDLEB | Apr 30, 2024 | 25.00 | -1.19 |
Cantargia | CANTA | Apr 30, 2024 | 3.34 | -2.74 |
Carbiotix | CRBX | Apr 30, 2024 | 0.07 | +6.57 |
Cardeon | CARDEO | Apr 30, 2024 | 0.02 | 0.00 |
Careium AB | CARE | Apr 30, 2024 | 28.20 | +0.71 |
Case | CASE | Apr 30, 2024 | 15.20 | +1.33 |
Castellum | CAST | Apr 30, 2024 | 133.30 | +1.18 |
Catella A | CATA | Apr 30, 2024 | 27.20 | -2.86 |
Catella B | CATB | Apr 30, 2024 | 30.40 | -0.33 |
Catena | CATE | Apr 30, 2024 | 487.00 | +0.83 |
Catena Media | CTM | Apr 30, 2024 | 8.68 | -1.03 |
Cavotec SA | CCC | Apr 30, 2024 | 16.15 | +0.62 |
CDON | CDON | Apr 30, 2024 | 132.00 | -3.65 |
Cedergrenska | CEDER | Apr 30, 2024 | 13.40 | +0.75 |
Cell Impact | CI | Apr 30, 2024 | 0.15 | +10.32 |
CellaVision | CEVI | Apr 30, 2024 | 225.50 | -0.88 |
Cereno Scientific B | CRNOB | Apr 30, 2024 | 3.85 | -2.23 |
ChargePanel AB (publ) | CHARGE | Apr 30, 2024 | 1.79 | +0.85 |
Checkin.com Group | CHECK | Apr 30, 2024 | 37.80 | +2.72 |
Cheffelo | CHEF | Apr 30, 2024 | 21.20 | -0.47 |
Chordate Medical Holding | CMH | Apr 30, 2024 | 0.06 | +6.32 |
Chosa Oncology AB | CHOSA | Apr 30, 2024 | 1.00 | -0.20 |
Christian Berner Tech Trade B | CBTTB | Apr 30, 2024 | 31.50 | 0.00 |
ChromoGenics | CHRO | Apr 30, 2024 | 6.74 | -0.59 |
Cibus Nordic Real Estate | CIBUS | Apr 30, 2024 | 144.65 | +3.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.